Oct 21, 2026 07:16AM
Oct 14, 2026 08:45AM
Aug 26, 2026 07:02AM
Aug 6, 2026 05:38PM
Jul 31, 2026 07:00AM
Jul 15, 2026 07:01AM
Jul 1, 2026 07:02AM INmune Bio files CORDStrom patent in U.S. after favorable PCT opinion
Jun 25, 2026 07:00AM
Jun 23, 2026 08:03AM
May 7, 2026 05:13PM
May 5, 2026 04:00PM
Mar 30, 2026 04:00PM
Mar 11, 2026 06:05AM
Feb 19, 2026 12:16PM INmune Bio to host webinar on RDEB treatment data
Feb 12, 2026 07:01AM
Feb 10, 2026 08:04AM
Jan 27, 2026 09:25AM
Oct 30, 2025 04:23PM
Aug 7, 2025 05:44PM
Aug 4, 2025 12:13PM
Aug 4, 2025 08:14AM INmune Bio completes prostate cancer trial, meets endpoints
Jun 30, 2025 04:37PM
Jun 30, 2025 04:01PM
Jun 30, 2025 02:24PM
Jun 30, 2025 01:49PM
Jun 30, 2025 10:36AM
Jun 30, 2025 07:30AM
Jun 27, 2025 12:16PM INmune Bio (INMB) Announces Approximately $19 Million Registered Direct Offering
Jun 26, 2025 04:42PM
Jun 26, 2025 04:01PM
Jun 24, 2025 10:47AM
Jun 23, 2025 10:53AM
Jun 10, 2025 04:02PM
Jun 4, 2025 06:18AM
May 8, 2025 04:14PM INmune Bio, Inc. (INMB) Tops Q1 EPS by 6c
Apr 16, 2025 07:01AM
Apr 1, 2025 07:02AM
Mar 31, 2025 04:54AM
Feb 12, 2025 07:03AM
Feb 12, 2025 05:12AM
Feb 11, 2025 06:53AM
Feb 10, 2025 07:03AM INmune Bio (INMB) to Submit FDA Biologics License Application Seeking Approval of CORDStrom
Jan 28, 2025 10:26AM
Jan 28, 2025 08:05AM
Jan 28, 2025 06:31AM
Oct 31, 2024 04:12PM
Sep 26, 2024 08:01AM
Sep 18, 2024 09:14AM
Sep 18, 2024 06:22AM BTIG Reiterates Buy Rating on INmune Bio Inc. (INMB)
Sep 17, 2024 08:31AM

483,092 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All